5

Adinath Bio-Labs

590088 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

2
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -13.2% over last 3 years.

Growth Rate

Net Income Growth
2%

Quarterly Results

Particulars Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016
Sales
9.88
5.78
0.3
0.28
0.32
0.45
0.22
0.22
0.18
0.19
0.19
0.16
0.11
Expenses
9.71
6.13
0.22
0.2
0.22
0.32
0.32
0.14
0.13
0.14
0.15
0.12
0.08
Operating Profit
0.17
-0.35
0.08
0.08
0.1
0.13
-0.1
0.08
0.05
0.05
0.04
0.04
0.03
OPM %
1.72%
-6.06%
26.67%
28.57%
31.25%
28.89%
-45.45%
36.36%
27.78%
26.32%
21.05%
25%
27.27%
Other Income
0.04
0.04
0.03
0.02
0.02
0
0.38
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.07
0.07
0.05
0.05
0.05
0.12
0.04
0.04
0.04
0.04
0.03
0.03
0.03
PBT
0.14
-0.38
0.06
0.05
0.07
0.01
0.24
0.04
0.01
0.01
0.01
0.01
0
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Net Profit
0.14
-0.38
0.05
0.04
0.06
0.01
0.24
0.04
0.01
0.01
0.01
0.01
0.01
EPS in Rs
0.01
-0.02
0
0
0
0
0.01
0
0
0
0
0
0
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Sales
21.82
32.5
56.45
42.17
42.85
1
1.35
0.81
0.56
0.05
0
0
Expenses
20.1
30.3
55.42
41.09
41.89
0.73
0.97
0.73
0.42
1.83
0.55
0.53
Operating Profit
1.72
2.2
1.03
1.08
0.96
0.27
0.38
0.08
0.14
-1.78
-0.55
-0.53
OPM %
7.88%
6.77%
1.82%
2.56%
2.24%
27%
28.15%
9.88%
25%
-3560%
—
—
Other Income
0.09
0.09
0.23
0.18
0.13
0.16
0.07
0.38
0.01
-4.43
-1.96
-2.88
Interest
0
0
0
0
0
0
0
0
0
0
0
0.01
Depreciation
0.31
0.33
0.39
0.56
0.4
0.29
0.28
0.16
0.11
0.09
0.01
0.01
PBT
1.5
1.96
0.87
0.7
0.69
0.14
0.17
0.3
0.04
-6.3
-2.52
-3.43
Tax %
34.67%
3.06%
0%
2.86%
0%
0%
-5.88%
53.33%
25%
11.59%
-0.79%
0%
Net Profit
0.98
1.9
0.87
0.68
0.7
0.14
0.17
0.14
0.02
-7.03
-2.51
-3.42
EPS in Rs
0.04
0.09
0.04
0.03
0.03
0.01
0.01
0.01
0
-0.32
-0.11
-0.15
Div. Payout %
67.56%
69.69%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Equity Capital
22.07
22.07
22.07
22.07
22.07
22.07
22.07
22.07
22.07
22.07
22.07
22.07
Reserves
4.37
4.72
5.59
6.27
6.97
7.11
7.08
7.23
-6.44
-13.47
-15.97
-19.4
Borrowings
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1.38
1.9
0.27
0.18
0.16
0.14
0.17
0.19
0.19
0.95
0.86
0.87
Total Liabilities
27.82
28.69
27.93
28.52
29.2
29.32
29.32
29.49
15.82
9.55
6.96
3.54
Fixed Assets
3.25
3.53
2.01
1.86
1.47
1.18
0.71
0.56
0.44
0.26
0.02
0.02
CWIP
1.86
2.22
2.27
1.87
1.87
1.87
1.87
1.87
1.87
0
0
0
Investments
1.27
1.27
1.27
0.56
0.56
2.96
2.96
0.56
0.54
0.03
0.03
0.03
Other Assets
21.44
21.67
22.38
24.23
25.3
23.31
23.78
26.5
12.97
9.26
6.91
3.49
Total Assets
27.82
28.69
27.93
28.52
29.2
29.32
29.32
29.49
15.82
9.55
6.96
3.54
Figures in ₹ Crores

Cash Flow

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Operating
-0.13
1.05
-1.41
-0.92
-0.13
-0.06
-0.13
-2.6
0.12
-0.54
-0.01
-0.03
Investing
0.14
-0.88
1.31
0.89
0.13
0.13
0.07
2.58
-0.17
0.52
0.02
0.03
Financing
0
0
0
0
0
0
0
0
0
0
0
0
Net Cash Flow
0.01
0.17
-0.1
-0.03
0
0.07
-0.06
-0.02
-0.05
-0.02
0.01
0
Free Cash Flow
-0.13
0.09
-0.33
-0.92
-0.13
-2.46
-0.13
-2.61
0.12
-0.44
-0.01
-0.03
CFO/OP
23
71
-131
-84
-14
-22
-34
-3,112
86
30
2
6
Figures in ₹ Crores

Ratios

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Debtor Days
124
88.61
47.14
75.04
66.7
2,562
122
279
404
4,526
—
—
Inventory Days
113
77.6
21.52
28.51
28.77
—
—
—
—
0
—
—
Days Payable
0.37
2.35
1
0.45
0.27
—
—
—
—
—
—
—
Cash Conversion Cycle
237
164
67.65
103
95.2
2,562
122
279
404
4,526
—
—
Working Capital Days
335
220
69.19
102
93.61
3,701
83.81
198
1,088
2,190
—
—
ROCE %
5.69%
7.36%
3.2%
2.5%
2.41%
0.48%
0.58%
0.38%
0.18%
-11.39%
-7.21%
-11.63%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Adinath Bio-Labs insights

55 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

Public74.25%Promot.25.75%As ofDec 2016

Documents

Frequently Asked Questions about Adinath Bio-Labs

What does Adinath Bio-Labs Ltd do?
Adinath Bio-Labs is an India-based company, which is engaged in trading in agricultural commodities and its allied products, and also dealing in other concern activities.
Where is Adinath Bio-Labs Ltd (590088) listed?
Adinath Bio-Labs Ltd trades under code 590088 on the BSE.
Which sector does Adinath Bio-Labs Ltd belong to?
Adinath Bio-Labs Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Adinath Bio-Labs is an India-based company, which is engaged in trading in agricultural commodities and its allied products, and also dealing in other concern activities.

Website adinathbio.com
Listed 2008-07-03
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/590088.md for Adinath Bio-Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List